« Back
Home /
Benralizumab

Benralizumab

Manufacturer	MedChem Express
Category	Antibodies Primary Antibodies
Type	Antibody Monoclonal
Specific against	other
Amount	1 mg
Item no.	HY-P9923-1mg
CASRN	1044511-01-4
eClass 6.1	32160702
eClass 9.0	42030590
Available
Product Description	Benralizumab (MEDI-563) is an interleukin-5 receptor α (IL-5Rα)-directed cytolytic monoclonal antibody that induces direct, rapid and nearly complete depletion of eosinophils via enhanced antibody-dependent cell-mediated cytotoxicity. Benralizumab can be used for severe eosinophilic asthma[1].
StorageTemperature	Store at 4°C for 2 years, do not freeze
Shipping	Blue Ice
Manufacturers Applications	COVID-19-immunoregulation
MolecularWeight	N/A
Clinical_Information	Launched
Manufacturers Research_Area	Inflammation/Immunology; Cancer
Solubility	H2O
Manufacturers Target	Apoptosis; Interleukin Related
Isoform	IL-5
Pathway	Apoptosis; Immunology/Inflammation
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Request delivery time